BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36870649)

  • 1. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
    Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
    Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
    Ashraf GM; DasGupta D; Alam MZ; Baeesa SS; Alghamdi BS; Anwar F; Alqurashi TMA; Sharaf SE; Al Abdulmonem W; Alyousef MA; Alhumaydhi FA; Shamsi A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
    Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
    Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.
    Shamsi A; Anwar S; Mohammad T; Alajmi MF; Hussain A; Rehman MT; Hasan GM; Islam A; Hassan MI
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32443670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease.
    Adnan M; DasGupta D; Anwar S; Shamsi A; Siddiqui AJ; Snoussi M; Bardakci F; Patel M; Hassan MI
    Front Pharmacol; 2023; 14():1276179. PubMed ID: 37795023
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
    Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
    J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.
    Anwar S; Shamsi A; Kar RK; Queen A; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2020 Oct; 161():596-604. PubMed ID: 32535203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.
    Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI
    J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
    Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
    Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
    Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches.
    Atiya A; Alsayari A; Bin Muhsinah A; Almaghaslah D; Bilgrami AL; Abdulmonem WA; Alorfi NM; DasGupta D; Ashraf GM; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023; 41(18):8824-8830. PubMed ID: 36376029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4.
    Anwar S; Khan S; Anjum F; Shamsi A; Khan P; Fatima H; Shafie A; Islam A; Hassan MI
    J Cell Biochem; 2022 Feb; 123(2):359-374. PubMed ID: 34751461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
    Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
    Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.
    Naz F; Sami N; Naqvi AT; Islam A; Ahmad F; Imtaiyaz Hassan M
    J Biomol Struct Dyn; 2017 Nov; 35(14):3194-3203. PubMed ID: 27748164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human microtubule affinity-regulating kinase 4 is stable at extremes of pH.
    Naz F; Singh P; Islam A; Ahmad F; Imtaiyaz Hassan M
    J Biomol Struct Dyn; 2016 Jun; 34(6):1241-51. PubMed ID: 26208600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
    Trinczek B; Brajenovic M; Ebneth A; Drewes G
    J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
    Anwar S; Shahwan M; Hasan GM; Islam A; Hassan MI
    Cell Signal; 2022 Nov; 99():110434. PubMed ID: 35961526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
    Khan P; Rahman S; Queen A; Manzoor S; Naz F; Hasan GM; Luqman S; Kim J; Islam A; Ahmad F; Hassan MI
    Sci Rep; 2017 Aug; 7(1):9470. PubMed ID: 28842631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.